Beta Bionics, Inc. — Director's Dealing 2025

Jan 30, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Beta Bionics, Inc. (BBNX)
CIK: 0001674632
Period of Report: 2025-01-29

Reporting Person: Wellington Hadley Harbor Aggregator IV, L.P. (N/A)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series E Preferred Stock	$		Class B Common Stock (2901599)		Direct

Footnotes

F1: Each share of Series E Preferred Stock (the "Preferred Stock") is convertible into shares of Class B Common Stock of the Issuer on a one-for-one basis without payment of further consideration. Upon the closing of the Issuer's initial public offering (the "IPO"), the Preferred Stock will convert into the number of shares of Class B Common Stock of the Issuer shown in column 3 and subsequently into an equal number of shares of Common Stock of the Issuer. The Preferred Stock has no expiration date.

F2: In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the IPO.